These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8826508)
1. Endothelin-1 in periaqueductal gray area of mice induces analgesia via glutamatergic receptors. D'Amico M; Berrino L; Maione S; Filippelli A; de Novellis V; Rossi F Pain; 1996; 65(2-3):205-9. PubMed ID: 8826508 [TBL] [Abstract][Full Text] [Related]
2. Involvement of periaqueductal gray area NMDA receptors in endothelin-induced behavioural effects. Maione S; D'Amico M; Berrino L; Filippelli A; Leyva J; Rossi F Eur J Pharmacol; 1993 Nov; 250(1):209-12. PubMed ID: 7907022 [TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 in rat periaqueductal gray area induces hypertension via glutamatergic receptors. D'Amico M; Berrino L; Maione S; Filippelli A; Pizzirusso A; Vitagliano S; Rossi F Hypertension; 1995 Apr; 25(4 Pt 1):507-10. PubMed ID: 7721391 [TBL] [Abstract][Full Text] [Related]
4. Hypotension to central endothelin-1: effect of glutamate receptor blockade. Hashim MA; Tadepalli AS Biochem Biophys Res Commun; 1994 Nov; 205(1):795-801. PubMed ID: 7999115 [TBL] [Abstract][Full Text] [Related]
5. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Morgan MM; Bobeck EN; Ingram SL Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608 [TBL] [Abstract][Full Text] [Related]
6. Selective and non-selective ET antagonists reveal an ET(A)/ET(B) receptor mediated ET-1-induced antinociceptive effect in PAG area of mice. D'Amico M; Di Filippo C; Rossi F Life Sci; 1997; 61(25):PL 397-401. PubMed ID: 9416772 [TBL] [Abstract][Full Text] [Related]
7. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse. Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389 [TBL] [Abstract][Full Text] [Related]
8. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model. Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975 [TBL] [Abstract][Full Text] [Related]
9. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Spinella M; Cooper ML; Bodnar RJ Pain; 1996 Mar; 64(3):545-552. PubMed ID: 8783320 [TBL] [Abstract][Full Text] [Related]
10. Excitatory amino acid receptors in the periaqueductal gray mediate the cardiovascular response evoked by activation of dorsomedial hypothalamic neurons. da Silva LG; Menezes RC; Villela DC; Fontes MA Neuroscience; 2006; 139(3):1129-39. PubMed ID: 16458440 [TBL] [Abstract][Full Text] [Related]
11. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats. Haghparast A; Gheitasi IP; Lashgari R Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798 [TBL] [Abstract][Full Text] [Related]
12. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Coderre TJ; Van Empel I Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409 [TBL] [Abstract][Full Text] [Related]
13. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399 [TBL] [Abstract][Full Text] [Related]
14. Metabotropic and ionotropic glutamate receptors mediate opposite effects on periaqueductal gray matter. Leyva J; Maione S; Pallotta M; Berrino L; Rossi F Eur J Pharmacol; 1995 Oct; 285(2):123-6. PubMed ID: 8566129 [TBL] [Abstract][Full Text] [Related]
15. Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system. Berrino L; Oliva P; Rossi F; Palazzo E; Nobili B; Maione S Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):437-43. PubMed ID: 11692227 [TBL] [Abstract][Full Text] [Related]
16. NMDA receptor and NO mediate ET-1-induced behavioral and cardiovascular effects in periaqueductal gray matter of rats. Ryu JS; Shin CY; Yang SJ; Lee TS; La HO; Song HJ; Yom YK; Huh IH; Sohn UD Arch Pharm Res; 2001 Feb; 24(1):64-8. PubMed ID: 11235814 [TBL] [Abstract][Full Text] [Related]
17. Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon beta-endorphin analgesia elicited from the ventrolateral periaqueductal gray. Spinella M; Znamensky V; Moroz M; Ragnauth A; Bodnar RJ Brain Res; 1999 May; 829(1-2):151-9. PubMed ID: 10350541 [TBL] [Abstract][Full Text] [Related]
18. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study. Campos F; Alfonso M; Vidal L; Faro LR; Durán R Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020 [TBL] [Abstract][Full Text] [Related]
19. Non-NMDA glutamate receptor antagonist injected into the hypothalamic paraventricular nucleus inhibits the prolactin response to formalin stress of male rats. Bodnár I; Bánky Z; Halász B Neurochem Res; 2006 Feb; 31(2):201-8. PubMed ID: 16518578 [TBL] [Abstract][Full Text] [Related]
20. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter. Nakai M; Maeda M Neuroscience; 2000; 98(3):449-57. PubMed ID: 10869839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]